Effectiveness of catheter ablation of atrial fibrillation in Belgian practice: A cohort analysis on administrative data

Europace

Volumn 15, Issue 5, 2013, Pages 663-668

  Van Brabandt, Hans ^a   Neyt, Mattias ^a   Devos, Carl ^a  

^a BELGIAN HEALTH CARE KNOWLEDGE CENTRE KCE   (Belgium)

Author keywords

Administrative database; Atrial fibrillation; Catheter ablation; Health technology assessment

Indexed keywords

AMIODARONE; CIBENZOLINE; DIGITALIS GLYCOSIDE; DILTIAZEM; DISOPYRAMIDE; FLECAINIDE; PROPAFENONE; QUINIDINE; SOTALOL; VERAPAMIL;

ADULT; ARTICLE; BELGIUM; CARDIAC PATIENT; CARDIOVERSION; CATHETER ABLATION; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; COST OF ILLNESS; DISEASE CONTROL; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HOSPITALIZATION; HUMAN; INSURANCE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PAROXYSMAL HEART ATRIUM FIBRILLATION; PRESCRIPTION; PRIORITY JOURNAL; RECURRENT DISEASE;

ATRIAL FIBRILLATION; BELGIUM; CATHETER ABLATION; COHORT STUDIES; FEMALE; HUMANS; INSURANCE CLAIM REPORTING; MALE; MIDDLE AGED; PREVALENCE; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 84877257052     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eut004     Document Type: Article

References (26)

1. Viles-Gonzalez JF, Fuster V, Halperin J, Calkins H, Reddy VY. Rhythm control for management of patients with atrial fibrillation: balancing the use of antiarrhythmic drugs and catheter ablation. Clin Cardiol 2011;34: 23-9.
2. Van Brabandt H, Neyt M, Devos C. Catheter Ablation of Atrial Fibrillation (HTA). Brussels: Belgian Health Care Knowledge Centre; 2012 September 26, 2012. Report No.: 184C.
3. Fitton A, Sorkin EM. Sotalol. An updated review of its pharmacological properties and therapeutic use in cardiac arrhythmias. Drugs 1993;46: 678-719.
4. Wann LS, Curtis AB, January CT, Ellenbogen KA, Lowe JE, Estes NA et al. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline): A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2011;123: 104-23.
5. Forleo GB, Mantica M, De Luca L, Leo R, Santini L, Panigada S et al. Catheter ablation of atrial fibrillation in patients with diabetes mellitus type 2: results from a randomized study comparing pulmonary vein isolation versus antiarrhythmic drug therapy. J Cardiovasc Electrophysiol 2009;20: 22-8.
6. Jais P, Cauchemez B, Macle L, Daoud E, Khairy P, Subbiah R et al. Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study. Circulation 2008;118: 2498-505.
7. Krittayaphong R, Sriratanasathavorn C, Dhumvibhat C, Nutakul T, Charernthai S, Kangkagate C. Radiofrequency catheter ablation of ventricular tachycardia from right ventricular outflow tract. J Med Assoc Thai 2003;86(Suppl 1):S1-7.
8. Mac Donald MR, Connelly DT, Hawkins NM, Steedman T, Payne J, Shaw M et al. Radiofrequency ablation for persistent atrial fibrillation in patients with advanced heart failure and severe left ventricular systolic dysfunction: A randomised controlled trial. Heart 2011;97: 740-7.
9. Oral H, Pappone C, Chugh A, Good E, Bogun F, Pelosi F Jr et al. Circumferential pulmonary-vein ablation for chronic atrial fibrillation. N Engl J Med 2006;354: 934-41.
10. Pappone C, Augello G, Sala S, Gugliotta F, Vicedomini G, Gulletta S et al. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study. J Am Coll Cardiol 2006;48: 2340-7.
11. Stabile G, Bertaglia E, Senatore G, De Simone A, Zoppo F, Donnici G et al. Catheter ablation treatment in patients with drug-refractory atrial fibrillation: A prospective, multi-centre, randomized, controlled study (Catheter Ablation For The Cure Of Atrial Fibrillation Study). Eur Heart J 2006;27: 216-21.
12. Wazni OM, Marrouche NF, Martin DO, Verma A, Bhargava M, Saliba W et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: A randomized trial. JAMA 2005;293: 2634-40.
13. Wilber DJ, Pappone C, Neuzil P, De Paola A, Marchlinski F, Natale A et al. Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: A randomized controlled trial. JAMA 2010;303: 333-40.
14. Nielsen JC, Johannessen A, Raatikainen P, Hindricks G, Walfridsson H, Kongstad O et al. Radiofrequency Ablation as Initial Therapy in Paroxysmal Atrial Fibrillation. N Engl J Med 2012;367: 1587-95.
15. Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J et al. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol 2010;3: 32-8.
16. Shah RU, Freeman JV, Shilane D, Wang PJ, Go AS, Hlatky MA. Procedural complications, rehospitalizations, and repeat procedures after catheter ablation for atrial fibrillation. J Am Coll Cardiol 2012;59: 143-9.
17. Arbelo E, Brugada J, Hindricks G, Maggioni A, Tavazzi L, Vardas P et al. ESC-EURObservational Research Programme: the Atrial Fibrillation Ablation Pilot Study, conducted by the European Heart Rhythm Association. Europace 2012;14: 1094-103.
18. Picano E. Sustainability of medical imaging. BMJ 2004;328: 578-80.
19. Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA et al. 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace 2012;14: 528-606.
20. Thrall G, Lane D, Carroll D, Lip GY. Quality of life in patients with atrial fibrillation: A systematic review. Am J Med 2006;119: 448, e1-19.
21. Wyse DG, Waldo AL, Di Marco JP, Domanski MJ, Rosenberg Y, Schron EB et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002;347: 1825-33.
22. de Denus S, Sanoski CA, Carlsson J, Opolski G, Spinler SA. Rate vs rhythm control in patients with atrial fibrillation: A meta-analysis. Arch Intern Med 2005; 165: 258-62.
23. Calkins H, Brugada J, Packer DL, Cappato R, Chen SA, Crijns HJ et al. HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation developed in partnership with the European Heart Rhythm Association (EHRA) and the European Cardiac Arrhythmia Society (ECAS); in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Endorsed and approved by the governing bodies of the American College of Cardiology, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, and the Heart Rhythm Society. Europace 2007;9: 335-79.
24. Mulder AA, Wijffels MC, Wever EF, Boersma LV. Freedom from paroxysmal atrial fibrillation after successful pulmonary vein isolation with pulmonary vein ablation catheter-phased radiofrequency energy: 2-year follow-up and predictors of failure. Europace 2012;14: 818-25.
25. Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation Developed with the special contribution of the European Heart Rhythm Association. Europace 2012;14: 1385-413.
26. Kirchhof P, Lip GY, Van Gelder IC, Bax J, Hylek E, Kaab S et al. Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options - a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference. Europace 2012;14: 8-27.